Published • loading... • Updated
Ethos Laboratories Announces Exclusive U.S. Launch of CNSDose™, Following Successful MolDX® ...
Summary by Enid News & Eagle
2 Articles
2 Articles
Post RegisterReposted by 
Enid News & Eagle
Enid News & EagleEthos Laboratories Announces Exclusive U.S. Launch of CNSDose™, Following Successful MolDX® ...
NEWPORT, Ky., July 07, 2026 (GLOBE NEWSWIRE) -- Ethos Laboratories today announced the national launch of CNSDose™, a pharmacogenomic testing platform that will be offered throughout the United States under an exclusive licensing agreement with Incite Genomics. The launch follows…
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
